Live feed/
Filings
/
SCHEDULE 13D
/
0001213900-26-041647
Stake: 5.30%
Shares: 115,071
CUSIP: G0411D123
Class: Class A ordinary shares, par value $0.01 per share
Item 4 — Purpose of Transaction
The Shares are held for investment purposes. Except as may occur in the ordinary course in the Reporting Person's capacity as an officer and director of the Issuer (including participating in discussions and decisions relating to the Issuer's operations, strategy, financing, and corporate governance), the Reporting Person does not currently have any plans or proposals that relate to or would result in any of the actions or transactions described in Items (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may, from time to time, review the Reporting Person's investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations, prospects, and market conditions, and may in the future acquire additional Shares or dispose of some or all of the Shares, subject to applicable law and the Reporting Person's insider status.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 1.00
26,338 shares short · +4.9% vs prior
Post-Filing Returns · since 2026-02-17 on APLMW
Anchor price 0.03 on closest trading day on/after 2026-02-17. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Other 13D/G Filings on Apollomics Inc.
| Filed | Form | Filer | Stake | Shares | |
| 2026-04-06 |
SCHEDULE 13D/A |
Chen Hung-Wen |
41.80% |
901,362 |
view → |
| 2023-11-01 |
SC |
ORBIMED ADVISORS LLC |
— |
— |
view → |
| 2023-10-02 |
SC |
ORBIMED ADVISORS LLC |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →